Grantham, Mayo, Van Otterloo & Co (GMO)’s Frontline FRO Stock Holding History
Bought
Maintained
Sold
Other funds holding FRO
F
Grantham, Mayo, Van Otterloo & Co (GMO)'s FRO Position: Q3 2021 in Review
Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Frontline (FRO) in Q3 2021, closing a stake of 61,662 shares — an estimated $557K sold.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in FRO in Q2 2020 and held it in 4 quarters. The position peaked at $6.72M in Q2 2020. 123 funds tracked by Wall St. Rank hold FRO as of Q3 2021.
- Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Frontline position as of Q3 2021 after selling out during the quarter.
- Grantham, Mayo, Van Otterloo & Co (GMO) sold 61,662 Frontline shares in Q3 2021, an estimated $557K.
- Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Frontline in Q2 2020 and held it in 4 quarters.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s Frontline position peaked at $6.72M in Q2 2020.
- 123 funds tracked by Wall St. Rank held Frontline as of Q3 2021.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q3 2021, filed 12 Nov 2021.